Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm Frier

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Mini Reviews in Medicinal Chemistry|February 3, 2004
Rhenium-188 and copper-67 radiopharmaceuticals for the treatment of bladder cancerMalcolm Frier
Current Pharmaceutical Design|September 24, 2004
Radionuclide imaging in drug developmentAlan C Perkins, Malcolm Frier
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 17, 2004
Usage of radiopharmaceuticals in the development of pharmaceutical drug delivery systems: validation of [99mTc]DTPA and [99mTc]ECDMariella Terán, Eduardo Savio, Andrea Paolino, et al.
BMC Nuclear Medicine|October 20, 2005
Hydrophilic and lipophilic radiopharmaceuticals as tracers in pharmaceutical development: in vitro--in vivo studiesMariella Terán, Eduardo Savio, Andrea Paolino, et al.
Journal of Drug Targeting|November 5, 2010
Lectin-directed enzyme activated prodrug therapy (LEAPT): Synthesis and evaluation of rhamnose-capped prodrugsPhilippe Garnier, Xiang-Tao Wang, Mark A Robinson, et al.
International Journal of Pharmaceutics|January 25, 2006
Esophageal transit of the weekly film-coated risedronate (Actonel) placebo tablet in subjects with KyphosisAlan C Perkins, Malcolm Frier, P Elaine Blackshaw, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2004
LEAPT: lectin-directed enzyme-activated prodrug therapyMark A Robinson, Stuart T Charlton, Philippe Garnier, et al.
International Journal of Pharmaceutics|March 14, 2002
Evaluation of Pulsincap to provide regional delivery of dofetilide to the human GI tractHoward N E Stevens, Clive G Wilson, Peter G Welling, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Mini Reviews in Medicinal Chemistry|February 3, 2004
Rhenium-188 and copper-67 radiopharmaceuticals for the treatment of bladder cancerMalcolm Frier
Current Pharmaceutical Design|September 24, 2004
Radionuclide imaging in drug developmentAlan C Perkins, Malcolm Frier
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 17, 2004
Usage of radiopharmaceuticals in the development of pharmaceutical drug delivery systems: validation of [99mTc]DTPA and [99mTc]ECDMariella Terán, Eduardo Savio, Andrea Paolino, et al.
BMC Nuclear Medicine|October 20, 2005
Hydrophilic and lipophilic radiopharmaceuticals as tracers in pharmaceutical development: in vitro--in vivo studiesMariella Terán, Eduardo Savio, Andrea Paolino, et al.
Journal of Drug Targeting|November 5, 2010
Lectin-directed enzyme activated prodrug therapy (LEAPT): Synthesis and evaluation of rhamnose-capped prodrugsPhilippe Garnier, Xiang-Tao Wang, Mark A Robinson, et al.
International Journal of Pharmaceutics|January 25, 2006
Esophageal transit of the weekly film-coated risedronate (Actonel) placebo tablet in subjects with KyphosisAlan C Perkins, Malcolm Frier, P Elaine Blackshaw, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2004
LEAPT: lectin-directed enzyme-activated prodrug therapyMark A Robinson, Stuart T Charlton, Philippe Garnier, et al.
International Journal of Pharmaceutics|March 14, 2002
Evaluation of Pulsincap to provide regional delivery of dofetilide to the human GI tractHoward N E Stevens, Clive G Wilson, Peter G Welling, et al.
Pageof 1